Vasculitis & polymyalgia rheumatica

PD-1 on CD8+T cells are low in Behçet's disease and is not normalised with type-I interferon

Clin Exp RheumatolPublished Mechanistic study

Authors' conclusion

The decreased PD-1 expression on CD8+T cells, along with the decreased PD-1, TIM-3 and TIGIT responses of CD8+T cells upon IFN-I stimulation, demonstrated an altered immune response in BD.

Study context

Population
Patients with Behçet's disease (BD) and age- and sex-matched healthy and diseased controls
Participants
37 / 24 / 29
Comparison
BD vs healthy and diseased controls
  • BDn = 37
  • Healthy controlsn = 24reference
  • Diseased controlsn = 29reference
Outcome
PD-1 on CD8+T cells and its response to IFN-I
Methodological detailsage- and sex-matched controls, in vitro stimulation
  • Age- and sex-matched controls
  • In vitro stimulation

Main finding

As reported in the abstract

  • PD-1 on CD8+T cells with potentially regulatory functions significantly lower in BD than in controls, regardless of disease activity
  • CD3 stimulation of PBMCs induced PD-1 expression in all groups
  • Increase of PD-1 on CD8+T cells with added interferon seen in controls, not in BD
  • Responsive increase of TIM-3 and TIGIT seen in controls, not in BD

Original publication

PD-1 on CD8+T cells are low in Behçet's disease and is not normalised with type-I interferon. Clin Exp Rheumatol. Published 3 February 2026. doi:10.55563/clinexprheumatol/u8iusx

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.